Med’s Industry
PeptiDream, PDRadiopharma, and Curium Launch Registrational Phase 2 Trial in Japan for 64Cu-PSMA-I&T Targeting Prostate Cancer
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter "PeptiDream")(Tokyo: 4587), PDRadiopharm...
October 17, 2025 | News
NUH and NUS Launch Singapore’s First Total-Body PET/CT Centre in Partnership with Siemens Healthineers
Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research i...
October 17, 2025 | News
Scanogen Secures FDA Breakthrough Device Designation for Rapid Sepsis Diagnostic in the United States
-Scanogen Inc., a molecular diagnostics company pioneering next-generation technologies for infectious disease detection, announced that the U.S. Food and ...
October 16, 2025 | Regulatory
Ascletis’ Denifanstat (ASC40) Achieves Phase III Success in Moderate-to-Severe Acne Vulgaris
Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulga...
October 15, 2025 | News
Asia University and NucleicAI Forge Alliance to Build Taiwan’s First Sovereign AI Life Science Data Platform
Asia University will partner with NucleicAI LLC, a next-generation platform and data company specializing in AI-driven genomics, precision m...
October 15, 2025 | News
Ascletis Selects ASC35 as Once-Monthly, Dual GLP-1/GIP Peptide Agonist Candidate for Obesity Treatment
- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, whic...
October 14, 2025 | News
Lundbeck’s Bexicaserin Receives Breakthrough Therapy Designation in China for Severe Childhood Epilepsies
Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies Novel 5HT2C mechanism des...
October 14, 2025 | News
Berlin Heals Completes Enrollment in First-in-Human Study of Less Invasive Heart Failure Therapy
Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a major Cardiology Congress ...
October 13, 2025 | News
Roche and OASES Partner to Advance Healthcare Innovation in Hong Kong
Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and stre...
October 13, 2025 | News
Sandstone Medical Expands Easydrip™ Plus Pen Needle Portfolio to Turkey
Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — announced the introduction of its Easydr...
October 13, 2025 | News
Gunze Medical Secures Exclusive Japan Distribution Rights for HistoSonics’ Noninvasive Histotripsy Therapy
Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medica...
October 10, 2025 | News
Australia’s Cyteph Completes Recruitment for Its First-in-Human Trial of CYT-101 in Glioblastoma
Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully completed...
October 09, 2025 | News
Thermo Fisher Introduces Gene Expression Profiling Test to Improve Precision in Lung Transplant Rejection Assessment
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury Thermo Fisher Scientific, the world leader in serv...
October 09, 2025 | News
Siemens Healthineers and NUH Singapore Join Forces to Advance Ultrasound Innovation for Liver Disease Detection
Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated ...
October 07, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
